ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 370 out of 680

$1.13M Total Retail Price of All Prescriptions

Rank: 61 out of 680

432 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 5,230 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$173 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 287 270 1 3
LEVOTHYROXINE SODIUM 284 236 2 2
PREDNISONE 214 180 3 50
HYDROCODONE-ACETAMINOPHEN 186 145 S3 4 4
OMEPRAZOLE 175 147 5 7
FUROSEMIDE 162 136 6 6
SUBOXONE 120 0 7 245
AMLODIPINE BESYLATE 118 89 8 1
METOPROLOL TARTRATE 113 103 9 12
PANTOPRAZOLE SODIUM 113 96 9 30
LOSARTAN POTASSIUM 105 79 11 21
METFORMIN HCL 99 95 12 8
METHADONE HCL 96 19 S2 13 234
ATENOLOL 92 79 14 19
SPIRONOLACTONE 90 66 15 82
GABAPENTIN 89 57 16 15
LISINOPRIL 85 77 17 5
CITALOPRAM HBR 79 69 18 22
AZITHROMYCIN 73 57 19 42
TAMSULOSIN HCL 72 68 20 34
MIRTAZAPINE 70 67 21 78
WARFARIN SODIUM 67 59 22 20
METOPROLOL SUCCINATE 67 64 22 13
ZOLPIDEM TARTRATE 67 53 22 17
AMITRIPTYLINE HCL 66 45 R 25 47
CRESTOR 66 44 25 25
CARVEDILOL 64 60 27 23
HYDROCHLOROTHIAZIDE 62 54 28 9
CLOPIDOGREL 60 53 29 26
ESTRADIOL 58 57 R 30 134
NEXIUM 56 56 31 16
PLAVIX 52 44 32 39
ATORVASTATIN CALCIUM 50 47 33 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.